Quantcast
Get breaking news alerts via email

Click here to manage your alerts
Letter: CBD should be allowed as medicine to help kids
This is an archived article that was published on sltrib.com in 2013, and information in the article may be outdated. It is provided only for personal research purposes and may not be reprinted.

"In the U.S. we demand the highest standards to prove the medicines our doctors prescribe are safe and reasonable effective." ("Letter: Trib editorial misleading; marijuana isn't medicine," Forum, Nov. 15) Has letter-writer Chris Stock never known of a medication approved by the FDA then pulled due to unsafe side effects?

I wonder if he would feel comfortable with his child taking a medication with these side effects: drooling, nausea, difficulty swallowing, tremor, Tardive dyskinesia, fainting, agitation, tachycardia, neuroleptic malignant syndrome, depression and mood swings?

Imagine your child taking four or more of these medications daily, each with its own list of side effects. The side effects related to CBD are minimal when compared to these "medicines."

Currently the government sees no benefit in marijuana as medicine, yet in 2003 the United States obtained a U.S. patent for cannabinoids as antioxidants and neuroprotectants. Why obtain a patent for a substance with no benefit?

Parents are not seeking legalization of marijuana. Parents are seeking CBD from a plant with less THC than is required to be considered hemp. To refuse parents the right to treat their struggling children is morally wrong.

Patrice Grossman

Provo

Article Tools

 Print Friendly
 
  • Search Obituaries
  • Place an Obituary

  • Search Cars
  • Search Homes
  • Search Jobs
  • Search Marketplace
  • Search Legal Notices

  • Other Services
  • Advertise With Us
  • Subscribe to the Newspaper
  • Access your e-Edition
  • Frequently Asked Questions
  • Contact a newsroom staff member
  • Access the Trib Archives
  • Privacy Policy
  • Missing your paper? Need to place your paper on vacation hold? For this and any other subscription related needs, click here or call 801.204.6100.